Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification
Modern Pathology2017Vol. 30(11), pp. 1516–1526
Citations Over TimeTop 11% of 2017 papers
Meixuan Chen, Mariacarla Andreozzi, Barbara A. Pockaj, Michael T. Barrett, Idris Tolgay Ocal, Ann E. McCullough, Maria E. Linnaus, James M. Chang, Jennifer H. Yearley, Lakshmanan Annamalai, Karen S. Anderson
Related Papers
- → Comparison of automated silver enhanced in situ hybridization and fluorescence in situ hybridization for evaluation of epidermal growth factor receptor status in human glioblastomas(2009)14 cited
- → Establishment of a new human malignant fibrous histiocytoma cell line, FU-MFH-1: cytogenetic characterization by comparative genomic hybridization and fluorescence in situ hybridization(2003)14 cited
- → Clinical utility of HPV detection by in situ hybridization and PCR in situ hybridization(1992)
- → Direct and Indirect In Situ PCR(2003)
- → PCR in situ hybridization and RT in situ PCR(2020)